Detalles de la búsqueda
1.
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy.
Future Oncol
; 18(32): 3609-3621, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305495
2.
Indirect treatment comparison of oral versus injectable azacitidine as maintenance therapy for acute myeloid leukemia.
Future Oncol
; 2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36507931
3.
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database.
Leuk Res
; 132: 107353, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562330
4.
The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United States.
J Manag Care Spec Pharm
; 29(9): 999-1008, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321967
5.
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United States.
J Med Econ
; 25(1): 903-911, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723576
6.
Treatment patterns and outcomes with luspatercept in patients with lower-risk myelodysplastic syndromes: A retrospective US cohort analysis.
Hemasphere
; 8(1): e38, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38434524
Resultados
1 -
6
de 6
1
Próxima >
>>